Literature DB >> 27182535

Telomerase Repeated Amplification Protocol (TRAP).

Ilgen Mender1, Jerry W Shay2.   

Abstract

Telomeres are found at the end of eukaryotic linear chromosomes, and proteins that bind to telomeres protect DNA from being recognized as double-strand breaks thus preventing end-to-end fusions (Griffith et al., 1999). However, due to the end replication problem and other factors such as oxidative damage, the limited life span of cultured cells (Hayflick limit) results in progressive shortening of these protective structures (Hayflick and Moorhead, 1961; Olovnikov, 1973). The ribonucleoprotein enzyme complex telomerase-consisting of a protein catalytic component hTERT and a functional RNA component hTR or hTERC- counteracts telomere shortening by adding telomeric repeats to the end of chromosomes in ~90% of primary human tumors and in some transiently proliferating stem-like cells (Shay and Wright, 1996; Shay and Wright, 2001). This results in continuous proliferation of cells which is a hallmark of cancer. Therefore, telomere biology has a central role in aging, cancer progression/metastasis as well as targeted cancer therapies. There are commonly used methods in telomere biology such as Telomere Restriction Fragment (TRF) (Mender and Shay, 2015b), Telomere Repeat Amplification Protocol (TRAP) and Telomere dysfunction Induced Foci (TIF) analysis (Mender and Shay, 2015a). In this detailed protocol we describe Telomere Repeat Amplification Protocol (TRAP). The TRAP assay is a popular method to determine telomerase activity in mammalian cells and tissue samples (Kim et al., 1994). The TRAP assay includes three steps: extension, amplification, and detection of telomerase products. In the extension step, telomeric repeats are added to the telomerase substrate (which is actually a non telomeric oligonucleotide, TS) by telomerase. In the amplification step, the extension products are amplified by the polymerase chain reaction (PCR) using specific primers (TS upstream primer and ACX downstream primer) and in the detection step, the presence or absence of telomerase is analyzed by electrophoresis. TSNT is, an internal standard control, amplified by TS primer. NT is its own reverse primer, which is not a substrate for telomerase. These primers are used to identify false-negative results by if the gel lacks internal control bands.

Entities:  

Year:  2015        PMID: 27182535      PMCID: PMC4863463          DOI: 10.21769/bioprotoc.1657

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  12 in total

1.  The serial cultivation of human diploid cell strains.

Authors:  L HAYFLICK; P S MOORHEAD
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

2.  Analysis of telomeres and telomerase.

Authors:  Brittney-Shea Herbert; Jerry W Shay; Woodring E Wright
Journal:  Curr Protoc Cell Biol       Date:  2003-11

3.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon.

Authors:  A M Olovnikov
Journal:  J Theor Biol       Date:  1973-09-14       Impact factor: 2.691

4.  Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity.

Authors:  W E Wright; J W Shay; M A Piatyszek
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

5.  Mammalian telomeres end in a large duplex loop.

Authors:  J D Griffith; L Comeau; S Rosenfield; R M Stansel; A Bianchi; H Moss; T de Lange
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

Review 6.  Telomeres and telomerase: implications for cancer and aging.

Authors:  J W Shay; W E Wright
Journal:  Radiat Res       Date:  2001-01       Impact factor: 2.841

7.  Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.

Authors:  Brittney-Shea Herbert; Ginelle C Gellert; Amelia Hochreiter; Krisztina Pongracz; Woodring E Wright; Daria Zielinska; Allison C Chin; Calvin B Harley; Jerry W Shay; Sergei M Gryaznov
Journal:  Oncogene       Date:  2005-08-04       Impact factor: 9.867

8.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

9.  Telomere Dysfunction Induced Foci (TIF) Analysis.

Authors:  Ilgen Mender; Jerry W Shay
Journal:  Bio Protoc       Date:  2015-11-20

10.  Telomere Restriction Fragment (TRF) Analysis.

Authors:  Ilgen Mender; Jerry W Shay
Journal:  Bio Protoc       Date:  2015-11-20
View more
  21 in total

1.  Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.

Authors:  Mindy K Graham; Jiyoung Kim; Joseph Da; Jacqueline A Brosnan-Cashman; Anthony Rizzo; Javier A Baena Del Valle; Lionel Chia; Michael Rubenstein; Christine Davis; Qizhi Zheng; Leslie Cope; Michael Considine; Michael C Haffner; Angelo M De Marzo; Alan K Meeker; Christopher M Heaphy
Journal:  Mol Cancer Res       Date:  2019-10-14       Impact factor: 5.852

2.  Long-range telomere regulation of gene expression: Telomere looping and telomere position effect over long distances (TPE-OLD).

Authors:  Wanil Kim; Jerry W Shay
Journal:  Differentiation       Date:  2017-11-22       Impact factor: 3.880

3.  AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC.

Authors:  Ilaria Laudadio; Francesca Orso; Gianluca Azzalin; Carlo Calabrò; Francesco Berardinelli; Elisa Coluzzi; Silvia Gioiosa; Daniela Taverna; Antonella Sgura; Claudia Carissimi; Valerio Fulci
Journal:  EMBO Rep       Date:  2018-12-27       Impact factor: 8.807

4.  Alternative splicing is a developmental switch for hTERT expression.

Authors:  Alex Penev; Andrew Bazley; Michael Shen; Jef D Boeke; Sharon A Savage; Agnel Sfeir
Journal:  Mol Cell       Date:  2021-04-13       Impact factor: 19.328

5.  ALT-FISH quantifies alternative lengthening of telomeres activity by imaging of single-stranded repeats.

Authors:  Lukas Frank; Anne Rademacher; Norbert Mücke; Stephan M Tirier; Emma Koeleman; Caroline Knotz; Sabrina Schumacher; Sabine A Stainczyk; Frank Westermann; Stefan Fröhling; Priya Chudasama; Karsten Rippe
Journal:  Nucleic Acids Res       Date:  2022-06-24       Impact factor: 19.160

Review 6.  Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity.

Authors:  Xuewen Liu; Yuchuan Wang; Guangming Chang; Feng Wang; Fei Wang; Xin Geng
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

Review 7.  Telomere length as a potential biomarker of coronary artery disease.

Authors:  Joyeeta Bhattacharyya; Keichiro Mihara; Deborshi Bhattacharjee; Manjarí Mukherjee
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375

8.  Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma.

Authors:  Patricia Reyes-Uribe; Maria Paz Adrianzen-Ruesta; Zhong Deng; Ileabett Echevarria-Vargas; Ilgen Mender; Steven Saheb; Qin Liu; Dario C Altieri; Maureen E Murphy; Jerry W Shay; Paul M Lieberman; Jessie Villanueva
Journal:  Oncogene       Date:  2018-04-26       Impact factor: 9.867

9.  Telomere Dysfunction Induced Foci (TIF) Analysis.

Authors:  Ilgen Mender; Jerry W Shay
Journal:  Bio Protoc       Date:  2015-11-20

10.  Telomere Restriction Fragment (TRF) Analysis.

Authors:  Ilgen Mender; Jerry W Shay
Journal:  Bio Protoc       Date:  2015-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.